Annual report pursuant to Section 13 and 15(d)

Segment Information (Tables)

Segment Information (Tables)

12 Months Ended

Jun. 30, 2013

Financial Information Relating to Operating Segments

Following is financial information relating to the operating segments (in thousands):


	Year Ended June 30,
	2013			2012			2011
External sales
Biotechnology	$	288,156		$	293,274		$	270,287
Clinical Controls		22,419			21,286			19,675

Consolidated net sales	$	310,575		$	314,560		$	289,962

Earnings before taxes
Biotechnology	$	156,910		$	162,763		$	164,332
Clinical Controls		8,746			8,002			7,222

Segment earnings before taxes		165,656			170,765			171,554
Other		(4,994	)		(8,570	)		(6,573	)

Consolidated earnings before taxes	$	160,662		$	162,195		$	164,981

Goodwill
Biotechnology	$	84,336		$	85,682		$	86,633
Clinical Controls		0			0			0

Consolidated goodwill	$	84,336		$	85,682		$	86,633

Intangible assets, net
Biotechnology	$	40,552		$	46,476		$	52,282
Clinical Controls		0			0			0

Consolidated intangible assets, net	$	40,552		$	46,476		$	52,282

Assets
Biotechnology	$	580,085		$	529,392		$	505,087
Clinical Controls		24,887			22,135			21,046

Segment assets		604,972			551,527			526,133
Other		173,126			167,797			91,537

Consolidated assets	$	778,098		$	719,324		$	617,670

Depreciation and amortization
Biotechnology	$	10,781		$	10,920		$	7,165
Clinical Controls		389			411			417

Segment depreciation and amortization		11,170			11,331			7,582
Other		1,151			1,136			1,118

Consolidated depreciation and amortization	$	12,321		$	12,467		$	8,700

Capital purchases
Biotechnology	$	3,248		$	4,021		$	2,707
Clinical Controls		6,914			597			149

Segment capital purchases		10,162			4,618			2,856
Other		12,292			1,399			774

Consolidated capital purchases	$	22,454		$	6,017		$	3,630

Financial Information Relating to Geographic Areas

Following is financial information relating to geographic areas (in thousands):


	Year Ended June 30,
	2013		2012		2011
External sales
United States	$	164,308	$	172,310	$	159,857
Europe		88,297		90,142		83,676
China		14,106		11,378		8,299
Other Asia		28,608		25,988		24,715
Rest of world		15,256		14,742		13,415

Total external sales	$	310,575	$	314,560	$	289,962

Long-lived assets
United States	$	103,541	$	87,968	$	88,802
Europe		7,129		7,528		7,819
China		117		141		96

Total long-lived assets	$	110,787	$	95,637	$	96,717

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References + Details